Showing 1 to 4 of 4 results
Genetic Test Predicts Childhood Obesity Risk with Improved Accuracy
A new genetic test, using a polygenic risk score (PGS), can predict a child's risk of developing severe obesity as an adult, with an accuracy twice that of previous methods, based on a global study of over five million individuals; the test works best for those of European ancestry.
Genetic Test Predicts Childhood Obesity Risk with Improved Accuracy
A new genetic test, using a polygenic risk score (PGS), can predict a child's risk of developing severe obesity as an adult, with an accuracy twice that of previous methods, based on a global study of over five million individuals; the test works best for those of European ancestry.
Progress
40% Bias Score
Saliva Test Shows Improved Accuracy in Prostate Cancer Risk Assessment
A new saliva test shows promise in identifying prostate cancer risk more accurately than the standard PSA blood test, with 40% of high-risk men in a UK study having cancer, compared to 25% with the PSA test, potentially reducing unnecessary biopsies.
Saliva Test Shows Improved Accuracy in Prostate Cancer Risk Assessment
A new saliva test shows promise in identifying prostate cancer risk more accurately than the standard PSA blood test, with 40% of high-risk men in a UK study having cancer, compared to 25% with the PSA test, potentially reducing unnecessary biopsies.
Progress
40% Bias Score
Genetic Test Accurately Predicts Childhood Obesity Risk
A new genetic test accurately predicts children's obesity risk from age 2.5, outperforming other methods and informing early interventions; it also predicts weight loss program responses in adults, potentially impacting public health strategies.
Genetic Test Accurately Predicts Childhood Obesity Risk
A new genetic test accurately predicts children's obesity risk from age 2.5, outperforming other methods and informing early interventions; it also predicts weight loss program responses in adults, potentially impacting public health strategies.
Progress
40% Bias Score
Trump's $500B AI Investment to Revolutionize Multiomics Healthcare
President Trump's announced $500 billion investment in AI infrastructure will significantly boost multiomics research, a field integrating various biological data layers to personalize healthcare, with the global market expected to grow from $2.7 billion in 2025 to $5.1 billion by 2029.
Trump's $500B AI Investment to Revolutionize Multiomics Healthcare
President Trump's announced $500 billion investment in AI infrastructure will significantly boost multiomics research, a field integrating various biological data layers to personalize healthcare, with the global market expected to grow from $2.7 billion in 2025 to $5.1 billion by 2029.
Progress
44% Bias Score
Showing 1 to 4 of 4 results